An interventional study of landmark and US_Ax in Ultrasound Guided Central Venous Cannulation, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 1 Month to 7 Years. Per ClinicalTrials.gov, last updated 2018-09-07.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Health services research
The purpose of this prospective randomized study was to compare landmark-subclavian venous access to ultrasound-guided axillary venous access when performed by pediatric anesthesiologists.
Objective: Subclavian vein catheterization may cause various complications. The investigators will compare the real-time ultrasound-guided axillary venous access vs. the landmark method- subclavian venous access in pediatric paticipants. (the needle insertion point of ultrasound-guided axillary venous is axillary vein. and the needle insertion point of landmark method is infraclavicular subclavian vein)
Design: Prospective randomized study.
Setting: Operating room of a tertiary medical center.
Interventions: The investigators will compare the ultrasound-guided axillary vein cannulation (66 paticipants) vs. the landmark method (66 pa- ticipants).
Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
landmark method_subclavian venous cannulation
Device: landmark
ultrasound guided axillary venous cannulation
Device: US_Ax
2nd access success rate
Time frame: interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
1st access success rate
Time frame: interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
3rd access success rate
Time frame: interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
total time
Time frame: interval between skin penetration and removal of the needle or catheter after central line insertion, an expected average of 120 seconds
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital